Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Antiparkinsonian medication masks motor signal progression in de novo patients

Brzezicki MA. et al, (2023), Heliyon, e16415 - e16415

Quantitative Oculomotor Assessment in Hereditary Ataxia: Systematic Review and Consensus by the Ataxia Global Initiative Working Group on Digital-motor Biomarkers

Garces P. et al, (2023), The Cerebellum

Quantitative Oculomotor Assessment in Hereditary Ataxia: Discriminatory Power, Correlation with Severity Measures, and Recommended Parameters for Specific Genotypes

Garces P. et al, (2023), The Cerebellum

Longitudinal monitoring of Progressive Supranuclear Palsy using Body-Worn movement sensors

ANTONIADES C. and FITZGERALD J., (2022), MDS

Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches

Bredemeyer O. et al, (2022), Frontiers in Digital Health, 4

Deep Brain Stimulation and Levodopa Affect Gait Variability in Parkinson Disease Differently

Su ZH. et al, (2022), Neuromodulation: Technology at the Neural Interface

Art Exists Because the Viewer Exists How François Morellet’s Triple X Neonly Influences Postural Control and Subjective Aesthetic Appreciation

Ward LM. et al, (2022), Leonardo, 55, 48 - 50

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study

Pereira MF. et al, (2022), BMJ Neurology Open, 4, e000214 - e000214

Parkinson's disease deficits in time perception to auditory as well as visual stimuli - A large online study.

Su ZH. et al, (2022), Front Neurosci, 16

Strategy Adherence: A Specific and Rapidly Progressive Deficit in Progressive Supranuclear Palsy

Brzezicki MA. et al, (2021), Movement Disorders Clinical Practice, 8, 1272 - 1274

Supranuclear gaze disorders - How do I approach them?

Antoniades C., (2021), JOURNAL OF THE NEUROLOGICAL SCIENCES, 429

Early detection of change in motor and cognitive symptoms in a longitudinal Progressive Supranuclear Palsy cohort - the OxQUIP study

Pereira M. and Antoniades C., (2021), MOVEMENT DISORDERS, 36, S254 - S254

Novel Cognitive Markers for Early Diagnosis and Monitoring of Progressive Supranuclear Palsy

Brzezicki M. and Antoniades C., (2021), MOVEMENT DISORDERS, 36, S251 - S251

Discriminating progressive supranuclear palsy from Parkinson's disease using wearable technology and machine learning

De Vos M. et al, (2020), Gait & Posture, 77, 257 - 263

The effect of levodopa on saccades – Oxford Quantification in Parkinsonism study

Lu Z. et al, (2019), Parkinsonism & Related Disorders, 68, 49 - 56

Oculomotor effects of medical and surgical treatments of Parkinson's disease.

ANTONIADES C. and FITZGERALD J., (2019), Progress in Brain Research

Quantifying eye and gait abnormalities in Parkinson's patients after Deep brain stimulation

Su Z. et al, (2019), MOVEMENT DISORDERS, 34

Treatment-induced eye movement response for Parkinson's disease

Su ZH. et al, (2019)

Oculomotor effects of medical and surgical treatments of Parkinson's disease.

Patel S. et al, (2019), 249, 297 - 305

The Influence of Deep Brain Stimulation on Eye Movements

Patel S. et al, (2019), ADVANCES IN TRANSLATIONAL NEUROSCIENCE OF EYE MOVEMENT DISORDERS, 377 - 387

Load More

Include forthcoming?